Corinne Rancinan

Once‐Daily Combination Therapy with Emtricitabine, Didanosine, and Efavirenz in Human Immunodeficiency Virus–Infected Patients

Jean‐Michel Molina, F Ferchal, Corinne Rancinan et al. · The Journal of Infectious Diseases · 2000 · 117 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus--Infected Patients

Geneviève Chêne, E. Angelini, Laurent Cotte et al. · Clinical Infectious Diseases · 2002 · 111 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Simplification Therapy with Once‐Daily Emtricitabine, Didanosine, and Efavirenz in HIV‐1–Infected Adults with Viral Suppression Receiving a Protease Inhibitor–Based Regimen: A Randomized Trial

Jean‐Michel Molina, Valérie Journot, Laurence Morand‐Joubert et al. · The Journal of Infectious Diseases · 2005 · 68 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +16

The ALBI Trial: A Randomized Controlled Trial Comparing Stavudine Plus Didanosine with Zidovudine Plus Lamivudine and a Regimen Alternating Both Combinations in Previously Untreated Patients Infected with Human Immunodeficiency Virus

Jean‐Michel Molina, Geneviève Chêne, F Ferchal et al. · The Journal of Infectious Diseases · 1999 · 67 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?

Corinne Rancinan, D. Neau, Marianne Savès et al. · AIDS · 2002 · 67 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17